Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2024-06-13 00:00:00 ET · period of report 2024-06-11 · accession 0000875320-24-000174 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-13 | 2024-06-11 | VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | F - Tax | $481.96 | -6,824 | 23.3K | -23% | -$3.29M | |
| 2024-06-13 | 2024-06-12 | VRTX | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off | S - Sale | $478.00 | -7,288 | 16.0K | -31% | -$3.48M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-11 | F | D | 6,824 | $481.96 | 23,260 | D | — | — | |
| 2 | Common | Common Stock | 2024-06-12 | S | D | 7,288 | $478.00 | 15,972 | D | — | — |